Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies.
Saengboon S, Ciurea SO, Popat UR, Ramdial JL, Bashir Q, Alousi AM, Chen J, Rondon G, Olson AL, Im JS, Hosing C, Shpall EJ, Champlin RE, Srour SA.
Saengboon S, et al. Among authors: olson al.
Blood Adv. 2024 Mar 23:bloodadvances.2023010625. doi: 10.1182/bloodadvances.2023010625. Online ahead of print.
Blood Adv. 2024.
PMID: 38607399